Global /China /Healthcare /Drug Manufacturers - General /688710

Shanghai InnoStar Bio-tech Co., Ltd.

688710

• SSE: 688710 • Delayed

67.98CNY 0%

10.06 USD

As of 19 June 2026, Shanghai InnoStar Bio-tech Co., Ltd. has a market cap of $1.42B USD, ranking #8796 globally and #2322 in China. It ranks #741 in the Healthcare sector, and #281 in the Drug Manufacturers - General industry.

Global Rank

8796

Country Rank

2322

Sector Rank

741

Industry Rank

281

Key Stats

Market Cap

$1.42BUSD

9.58B CNY

Enterprise Value

$1.26BUSD

8.49B CNY

Revenue (TTM)

$120.06MUSD

811.33M CNY

EBITDA (TTM)

$12.99MUSD

87.78M CNY

Net Income (TTM)

-$4.52MUSD

-30.52M CNY

EBITDA Margin

11%

Profit Margin

-3.8%

PS Ratio

11.8

PB Ratio

4.1

EV/EBITDA

92.3

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Yan Chang open_in_new

Employees

1,092

Founded

2010

Website

innostar.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-4%	3%	15%	53%	54%	116%	87%	87%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688710 ISIN: CNE1000078J7 Shares Out.: Shares Outstanding: 90.694M¹ Shares Float: 67.704M² TV: TradingView: SSE: 688710 SA: Stock Analysis: SHA: 688710 YF: Yahoo Finance: 688710.SS GF: Google Finance: SHA: 688710 BA: Barron's: 688710 MS: Morningstar: XSHG: 688710	67.98 CNY	TV: TradingView: SSE: 688710 SA: Stock Analysis: SHA: 688710 YF: Yahoo Finance: 688710.SS GF: Google Finance: SHA: 688710 BA: Barron's: 688710 MS: Morningstar: XSHG: 688710

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Shanghai InnoStar Bio-tech Co., Ltd.

Shanghai InnoStar Bio-tech Co., Ltd. provides drug research and development services in China and internationally. The company offers screening and discovery, nonclinical assessment stage, and clinical development stage services in the areas of chemical products, biologics, cell and gene therapeutics, radiopharmaceuticals, and traditional Chinese medicines. The company was founded in 2010 and is based in Shanghai, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$54.0B 364.89B CNY 4K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.78B 336.36B CNY 3K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.51B 223.48B HKD 2K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 1K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.56B 111.89B CNY 1K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 1K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 54K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 38K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 25K%	97.4	United States
Roche Holding AG SIX: RO	$321.45B 256.25B CHF 23K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$287.52B 215.59B GBP 20K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.59B 218.9B CHF 19K%	20.5	Switzerland

chevron_leftBack